Co-founder and managing partner, Quadria Capital
Abrar Mir is the co-founder and Managing Partner of Quadria Capital, the largest healthcare focused private equity firm in Asia with the recent closing of its third investment vehicle, a US$304m healthcare private equity fund, in June 2015.
Abrar is actively involved in managing the firm and serves on the fund’s Investment Committee. Abrar has led private equity and capital markets transactions with an aggregate value of over US$40 billion across Asia, US and Europe. Abrar currently serves on the boards of Medica Synergie, Soho Global Health, Orilus Investments and Medisia Investment Holdings.
Prior to founding Quadria Capital, Abrar was Global Head of Healthcare at Religare Capital Markets. Before that he was a Managing Director at Bank of America Merrill Lynch in London where he was part of the senior leadership team that led the bank’s healthcare investment banking strategy in Europe and Emerging Markets.
Abrar received a M.Phil in International Law from the University of Cambridge and is fluent in five languages.
“Network with C-Suite and senior industry leaders at our annual Summit and prestigious awards ceremony
HealthInvestor Asia (HIA) is the definitive source of financial intelligence for Apac’s growing healthcare markets.
HIA’s dedicated coverage of corporate and capital market activity in the healthcare sector provides independent and authoritative insight for investors, lenders, advisors and healthcare firms operating across the region.
By focusing specifically on the health sector, HIA provides forensic analysis of this vital and growing market.
HIA’s market-leading editorial coverage enables readers to grasp the complexities of the region and follow the flow of investment across health systems in Asia. Its market commentary and analysis is an invaluable tool in identifying trends and opportunities and its focused reporting allows readers to keep up to date with this fast-moving and exciting sector.
Paul Routley | +44(0)207 104 2006
Veena Gupta | +44(0)207 104 2058
Ivan Ujvari | +44(0)20 7104 2000